Yi Chen analyst

Currently out of the existing stock ratings of Yi Chen, 498 are a BUY (91.04%), 48 are a HOLD (8.78%), 1 are a SELL (0.18%).

Yi Chen

Work Performance Price Targets & Ratings Chart

Analyst Yi Chen, carries an average stock price target met ratio of 34.31% that have a potential upside of 48.27% achieved within 207 days. Previously, Yi Chen worked at HC WAINWRIGHT.

Yi Chen’s has documented 1,028 price targets and ratings displayed on 55 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on OCUL, Ocular Therapeutix at 07-Oct-2025.

Wall Street Analyst Yi Chen

Analyst best performing recommendations are on CELC (CELCUITY LLC).
The best stock recommendation documented was for CNTG (CENTOGENE B V) at 6/28/2023. The price target of $1.5 was fulfilled within 1 day with a profit of $0.08 (5.06%) receiving and performance score of 50.63.

Average potential price target upside

ASLN Aslan Pharmaceuticals Ltd ADR AZRX AzurRx BioPharma IDXG Interpace Biosciences APDN Applied DNA Sciences CODX Co-Diagnostics HTGM HTG Molecular Diagnostics KALA Kala Pharmaceuticals OCDX Ortho Clinical Diagnostics Holdings plc OCUL Ocular Therapeutix RNLX Renalytix AI EYPT Eyepoint Pharmaceuticals KPRX Kiora Pharmaceuticals MOTS Motus GI Holdings PRPH ProPhase Labs VACC VIVO Meridian Bioscience BLCO Bausch + Lomb Corp SRTS Sensus Healthcare ZYXI Zynex VERU Veru FWBI First Wave BioPharma ALIM Alimera Sciences ANIX Anixa Biosciences BLTE Belite Bio ADR CLSD Clearside Biomedical CNTG Centogene B V ICCM Icecure Medical MYNZ Mainz Biomed BV NMRD Nemaura Medical OPK Opko Health ANGO AngioDynamics DRTS Alpha Tau Medical Ltd LFMD LifeMD OPGN OpGen AADI Aadi Bioscience BPTH Bio Path Holdings CDNA Caredx CELC Celcuity LLC CHEK Check Cap Ltd MITO Stealth BioTherapeutics Corp XRAY Dentsply Sirona EYEN Eyenovia RGNX Regenxbio GLSI Greenwich Lifesciences  OBIO Orchestra BioMed Holdings OCS Oculis Holding AG Ordinary shares SMTI Sanara Medtech TRML Tourmaline Bio BLFS BioLife Solutions BNGO Bionano Genomics CTRP Trip.com Group ELDN Eledon Pharmaceuticals HROW Harrow Health LPCN Lipocine TCOM Trip.com Group Ltd ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 years 5 months 19 days ago
(03-May-2024)

2/5 (40%)

$13.4 (372.22%)

248

Buy

$15

1 years 7 months 9 days ago
(13-Mar-2024)

1/9 (11.11%)

$11.06 (280.71%)

11

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yi Chen is most bullish on?

Potential upside of $33.69 has been obtained for KALA (KALA PHARMACEUTICALS)

Which stock is Yi Chen is most reserved on?

Potential downside of $0.1 has been obtained for TRML (TOURMALINE BIO)

What Year was the first public recommendation made by Yi Chen?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?